OpGen, Inc. (OPGN) Financials

Stock symbol OPGN is outdated, potentially delisted? Maybe it is available on other exchange?

OPGN Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2024	5.5 million	2.5 million
June 30, 2024	2.9 million	14.5 million
March 31, 2024	3.0 million	13.7 million
Dec. 31, 2023	1.9 million	13.4 million

OPGN Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2024	-2.8 million	1530
June 30, 2024	-720212	368391
March 31, 2024	-1.1 million	188237
Dec. 31, 2023	-1.7 million	97806

OPGN Net Income

No data available :(

OPGN Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2024	1.6 million	1.9 million	2.1 million
June 30, 2024	168114	1.9 million	2.1 million
March 31, 2024	267493	4.0 million	2.1 million
Dec. 31, 2023	1.2 million	2.0 million	2.2 million

OPGN Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2024	6.6 million
June 30, 2024	1.3 million
March 31, 2024	1.3 million
Dec. 31, 2023	1.3 million

OPGN Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2024	-	488	783397	14846
June 30, 2024	-	22964	1.6 million	25327
March 31, 2024	914	25856	1.8 million	128646
Dec. 31, 2023	914	329363	1.5 million	260797

OPGN Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2024	-	-
June 30, 2024	28000	-41600
March 31, 2024	168149	74811
Dec. 31, 2023	1.1 million	1.2 million

OPGN Revenue by Segment

Graph available only for paid members. Upgrade to see it.

OPGN

Price: $24.75

52 week price:

0.00

34.00

Earnings Per Share: 0.18 USD

P/E Ratio: 137.50

Exchange: PNK

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 232100

Ebitda: -3.0 million

Market Capitalization: 251.2 million

Links:

OPGN on Yahoo Finance